33.89 0.00 (0.00%)
After hours: 4:00PM EDT
|Bid||33.82 x 900|
|Ask||33.93 x 1100|
|Day's Range||33.57 - 34.89|
|52 Week Range||19.92 - 41.95|
|Beta (5Y Monthly)||-0.38|
|PE Ratio (TTM)||67.78|
|Earnings Date||Apr 08, 2020|
|Forward Dividend & Yield||0.24 (0.71%)|
|Ex-Dividend Date||Jan 23, 2020|
|1y Target Est||39.50|
Simulations Plus today announced a new collaboration with a large pharmaceutical partner to enhance its HTPK Simulation Module in ADMET Predictor.
Simulations Plus announced today that it will report 2nd quarter fiscal year 2020 financial results on April 9, 2020, with a webcast at 4:15 p.m. EDT.
Simulations Plus announced today it has acquired Lixoft of Paris, adding Monolix Suite to its software offerings and an established European presence.
Simulations Plus' (SLP) new COVID-19 focused offering is expected to drive the top line and give it a competitive edge in simulations software market.
Simulations Plus announced today the launch of its COVID-19 ACT Program to provide expedited, expert consulting assistance in coronavirus research.
Simulations Plus today announced the addition of Sandra Suarez-Sharp as Vice President, Regulatory Affairs to lead the new Regulatory Strategies team.
Regardless of the success (or failure) of a new drug development, this company earns a profit Continue reading...
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...
DILIsym Services, a Simulations Plus company, in partnership with a large pharmaceutical company, is developing a QSP model focused on heart failure.
Simulations Plus, Inc. (NASDAQ:SLP) defied analyst predictions to release its first-quarter results, which were ahead...
How far off is Simulations Plus, Inc. (NASDAQ:SLP) from its intrinsic value? Using the most recent financial data...
Simulations Plus (SLP) delivered earnings and revenue surprises of 10.00% and 12.32%, respectively, for the quarter ended November 2019. Do the numbers hold clues to what lies ahead for the stock?
Simulations Plus (SLP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Before we spend days researching a stock idea we like to take a look at how hedge funds and billionaire investors recently traded that stock. Russell 2000 ETF (IWM) lagged the larger S&P 500 ETF (SPY) by more than 10 percentage points since the end of the third quarter of 2018. This means hedge funds […]
Long term investing can be life changing when you buy and hold the truly great businesses. While the best companies...
Simulations Plus (SLP) delivered earnings and revenue surprises of 22.22% and 6.80%, respectively, for the quarter ended August 2019. Do the numbers hold clues to what lies ahead for the stock?